Musculoskeletal pain:
Indications for: Orphenadrine Citrate Extended-Release
Painful musculoskeletal conditions.
Adult Dosage:
100mg twice daily (AM and PM).
Children Dosage:
Not recommended.
Orphenadrine Citrate Extended-Release Contraindications:
Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis.
Orphenadrine Citrate Extended-Release Warnings/Precautions:
Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers.
See Also:
Orphenadrine Citrate Extended-Release Classification:
Anticholinergic.
Orphenadrine Citrate Extended-Release Interactions:
Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone.
Adverse Reactions:
Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset.
Note:
Formerly known under the brand name Norflex.
How Supplied:
Contact supplier
